Oral Curcumin With Piperine as Adjuvant Therapy for the Treatment of COVID-19: A Randomized Clinical Trial

Background: Coronavirus disease-2019 (COVID-19) has a wide range of pathophysiological effects. Curcumin, an active constituent of Curcuma longa (turmeric), has several properties, including anti-inflammatory, antioxidant, antiviral, anti-thrombotic, and anti-proliferative effects, which make it a p...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Front Pharmacol
Main Authors: Pawar, Kirti S, Mastud, Rahul N, Pawar, Satheesh K, Pawar, Samragni S, Bhoite, Rahul R, Bhoite, Ramesh R, Kulkarni, Meenal V, Deshpande, Aditi R
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2021
Teme:
Pharmacology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8193734/
https://ncbi.nlm.nih.gov/pubmed/34122090
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2021.669362
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki